Serena Hreich-Dit
Nice, 06108, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Plasmatic Inactive IL-18 Predicts a Worse Overall Survival for Advanced Non-Small-Cell Lung Cancer with Early Metabolic Progression after Immunotherapy Initiation.
Journal: Cancers
Published: April 12, 2024
Activation of the P2RX7/IL-18 pathway in immune cells attenuates lung fibrosis.
Journal: eLife
Published: February 01, 2024
The Role of IL-18 in P2RX7-Mediated Antitumor Immunity.
Journal: International journal of molecular sciences
Published: April 26, 2023
Protocol for Evaluating In Vivo the Activation of the P2RX7 Immunomodulator.
Journal: Biological procedures online
Published: August 30, 2022
To inhibit or to boost the ATP/P2RX7 pathway to fight cancer-that is the question.
Journal: Purinergic signalling
Published: June 01, 2021
A Novel Screen for Expression Regulators of the Telomeric Protein TRF2 Identified Small Molecules That Impair TRF2 Dependent Immunosuppression and Tumor Growth.
Journal: Cancers
Published: April 25, 2021
A small-molecule P2RX7 activator promotes anti-tumor immune responses and sensitizes lung tumor to immunotherapy.
Journal: Nature communications
Published: December 20, 2019
Alternative splicing of P2RX7 pre-messenger RNA in health and diseases: Myth or reality?
Journal: Biomedical journal
Published: April 02, 2019
Showing 1-9 of 9
Last Updated: 09/26/2026